Moodys Investors Service - Rite Aid Corporation (RAD) Moodys upgrades Rite Aids PDR to Caa1-PD/LD

Report

Moody's Investors Service

EUR 167.87 For Business Accounts Only

Moody's upgrades Rite Aid's PDR to Caa1-PD/LD

Rating Action: Moody's upgrades Rite Aid's PDR to Caa1-PD/LD. Global Credit Research- 09 Dec 2019. New York, December 09, 2019-- Moody's Investors Service today upgraded Rite Aid Corporation's Probability of Default rating to Caa1-PD from Caa3-PD and appended the PDR with the "/ LD" designation.

09/12/2019 5 EN

Underlying

Rite Aid Corporation

Rite Aid is a pharmacy retail healthcare company. The company's Retail Pharmacy segment sells brand and generic prescription drugs, as well as an assortment of front-end products including health and beauty aids, personal care products, seasonal merchandise, and a private brand product line. The company's Pharmacy Services segment provides pharmacy benefit management (PBM) options through its EnvisionRxOptions and MedTrak PBMs, respectively. EnvisionRxOptions also provides mail-order and specialty pharmacy services through EnvisionPharmacies; a claims adjudication software platform in Laker Software; and a national Medicare Part D prescription drug plan through its EnvisionRx Plus product offering.

See profile

US7677548726 New York Stock Exchange United States

Provider

Moody's Investors Service

Moody's Investors Service is a leading provider of credit ratings, research, and risk analysis. Moody's commitment and expertise contributes to transparent and integrated financial markets, protecting the integrity of credit. Our ratings and analysis track debt covering more than:

130 countries
11,000 corporate issuers
21,000 public finance issuers
76,000 structured finance obligations

Credit ratings and research help investors analyze the credit risks associated with fixed-income securities. Such independent credit ratings and research also contribute to efficiencies in fixed-income markets and other obligations, such as insurance policies and derivative transactions, by providing credible and independent assessments of credit risk.

Moody’s default studies validate our predictive ratings. Our published research and investor briefings draw thousands of attendees each year and keep investors current with the rationale underlying our credit opinions.

See profile

Other Reports on these Companies

BusinessWire

Rite Aid Takes Steps to Accelerate Transformation and Position Company for Long-Term Success

PHILADELPHIA--(BUSINESS WIRE)-- Rite Aid Corporation (NYSE: RAD) (“Rite Aid” or the “Company”) today announced it has reached an agreement in principle with certain of its senior secured noteholders on the terms of a financial restructuring plan that will allow the Company to accelerate its ongoing business transformation. Implementing the contemplated restructuring plan will significantly reduce the Company’s debt, increase its financial flexibility and enable it to execute on key initiatives. In connection with this, Rite Aid has initiated a voluntary court-supervised process under Chapter 1...

October 16, 2023 October 16, 2023 1 EN

BusinessWire

Rite Aid Corporation Appoints Jeffrey S. Stein Chief Executive Officer

PHILADELPHIA--(BUSINESS WIRE)-- Rite Aid Corporation (NYSE: RAD) (“Rite Aid” or the “Company”) today announced that its Board of Directors has appointed Jeffrey S. Stein as Chief Executive Officer (CEO), Chief Restructuring Officer (CRO) and a member of the Board of Directors, effective immediately. Mr. Stein succeeds Elizabeth (“Busy”) Burr, who has served as Interim CEO of Rite Aid since January 2023. Ms. Burr will continue to serve on the Company’s Board. Mr. Stein brings more than three decades of experience as a leader and executive director at both public and private companies. Mr. Ste...

October 16, 2023 October 16, 2023 1 EN

Vermilion Research

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

EUR 46.63

June 24, 2022 June 24, 2022 1 EN

Moody's Ratings announces completion of a periodic review of ratings of CPI Property Group

Moody's Ratings (Moody's) has completed a periodic review of the ratings of CPI Property Group (CPI) and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 26 April 2024 in which Moody's reassessed the appropriateness of the ratings in th...

17m 17m 1 EN

Moody's Ratings affirms EVN`s A1 rating; stable outlook

Moody's Ratings (Moody's) has today affirmed the A1 ratings of the euro medium term notes of EVN AG (EVN). Concurrently, Moody's has affirmed the (P)A1 rating of the senior unsecured euro medium term note (EMTN) programme. The outlook remains stable. A full list of affected ratings can be found at...

EUR 167.87

19m 19m 1 EN

Moody's Ratings assigns Aa1 to Arlington, TX's drainage revenue bonds; stable outlook

Moody's Ratings (Moody's) has assigned a Aa1 rating to the City of Arlington, TX's proposed $9 million Municipal Drainage Utility System Revenue Bonds, Series 2024. Concurrently, Moody's has affirmed the Aa1 rating on the system's outstanding parity debt. After the sale, the system will have $60.7 m...

EUR 167.87

20m 20m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN